Schircks證書

Schircks Laboratories, Switzerland was founded by Dr. B. Schircks in 1980 to synthesize pteridines. The company is independently owned and operated. Schircks Laboratories has ceased production of tetrahydrobiopterin. Biomarin has taken over the US market and Merck Serono the European market. They will continue to expand. They are responsible for the supply of tetrahydrobiopterin (Sapropterin dihydrochloride) in tablet form (Kuvan).

Over 100 other pteridines are synthesized by Schircks Laboratories which are mainly used in science and clinical diagnostic applications. We are constantly developing and improving syntheses and starting new syntheses to meet the demands of research and development groups worldwide.

Please note that this website is continually updated and the price lists found here are always valid. Our price lists are not changed on a yearly basis but are valid from the date noted until further notice.

*
We welcome all suggestions per mail including other links you’d like to see added.

瑞士的Schircks實驗室由B. Schircks博士于1980年建立，用于合成蝶呤。公司是獨立擁有和經營的。Schircks實驗室已經停止生產四氫生物蝶呤。Biomarin已經占領了美國市場，而默克雪蘭諾則占領了歐洲市場。它們將繼續擴張。他們負責供應片劑形式的四氫生物蝶呤(鹽酸沙丙喋呤)。

Schircks實驗室合成了100多種其他翼teridines，主要用于科學和臨床診斷應用。我們不斷開發和改進合成物，并開始開發新的合成物，以滿足研發團隊的需求。

請注意，這個網站是不斷更新的，在這里找到的價格清單總是有效的。我們的價格單不會每年更改，但從通知日期起有效，直到另行通知為止。